ABSI: Absci Corporation Projected Future Earnings

Absci is optimizing resources by outsourcing computations and logistics to external partners. The high value of its AI protein design platform provides significant pricing power, which validates the projected volume of future profits. The value of determines this parameter level. Explosive growth in B2B contracts with pharma behemoths and royalty rights are creating a sustainable drug development ecosystem.

ABSI: Absci Expected Profit 07/04/2022 - 11/12/2026

Analytical breakdowns for Absci

- share price and consensus valuation forecast:

Stock Price Absci|ABSI - Broker Consensus Forecast

- market capitalization information:

Market Capitalization Absci|ABSI - Enterprise Value

- book capitalization indicators:

Book Value per Share Absci|ABSI - Company Book Value|Market Value to Book Value Ratio absci.com|ABSI - Company Total Asset Base

- debt and liquidity details:

- earnings and valuation multiples information:

ABSI - Net Financial Result|Projected Future Earnings Absci|ABSI - Business Payback Period|Forward P/E Multiple Absci Corporation|ABSI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Absci|ABSI - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Absci|ABSI - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months absci.com|ABSI - Net earnings per share growth this year|Earnings growth forecast for next year Absci

Initial company analysis:Absci, ABSI

To stress-test positions, an investor must evaluate the discounted value of future cash flows, which determines the asset's fair price and the risk of overpayment. The integration of AI and biology at Absci (ABSI) creates potential for breakthrough drugs, which is reflected in profit targets that link market capitalization to the efficiency of attracting top-tier talent and the future monetization of their developments.

Main competitors